PURPOSE: Cell lines have become an essential component for the investigation of cancer. We have developed a panel of cell lines derived from human urothelial cancers and we describe some of their important characteristics. MATERIALS AND METHODS: Ten human urothelial cancer cell lines were characterized by their growth in athymic nude mice, CAR expression and their susceptibility to adenoviral mediated transfer of the green fluorescence protein gene. TP53 mutation status and immunochemical analysis of p53, pRB and p16 were also examined. RESULTS: Five cell lines rapidly produced tumors in athymic nude mice. Two cell lines produced tumors in 1 month, 1 produced them in 3 months and 2 were nontumorigenic. The cell lines varied in CAR expression and in their susceptibility to adenoviral mediated gene transduction. There was no direct correlation between CAR expression and susceptibility to adenoviral mediated gene transduction. Seven cell lines had TP53 mutations, of which 2 had large deletions and did not express p53 protein by immunostaining. All cell lines expressed abnormal pRB by immunochemical analysis (3 had no staining and 7 had homogenously strong staining) and 8 did not express p16 (7 showed homogeneously strong pRB staining). CONCLUSIONS: Our panel of 10 human urothelial cell lines differed in genetic alterations, growth in nude mice, susceptibility to adenoviral mediated gene transduction, and expression of p53, p16 and pRB. The availability of various urothelial cancer cell lines with differing genotypic and phenotypic features will facilitate further research into bladder cancer.
PURPOSE: Cell lines have become an essential component for the investigation of cancer. We have developed a panel of cell lines derived from humanurothelial cancers and we describe some of their important characteristics. MATERIALS AND METHODS: Ten humanurothelial cancer cell lines were characterized by their growth in athymic nude mice, CAR expression and their susceptibility to adenoviral mediated transfer of the green fluorescence protein gene. TP53 mutation status and immunochemical analysis of p53, pRB and p16 were also examined. RESULTS: Five cell lines rapidly produced tumors in athymic nude mice. Two cell lines produced tumors in 1 month, 1 produced them in 3 months and 2 were nontumorigenic. The cell lines varied in CAR expression and in their susceptibility to adenoviral mediated gene transduction. There was no direct correlation between CAR expression and susceptibility to adenoviral mediated gene transduction. Seven cell lines had TP53 mutations, of which 2 had large deletions and did not express p53 protein by immunostaining. All cell lines expressed abnormal pRB by immunochemical analysis (3 had no staining and 7 had homogenously strong staining) and 8 did not express p16 (7 showed homogeneously strong pRB staining). CONCLUSIONS: Our panel of 10 human urothelial cell lines differed in genetic alterations, growth in nude mice, susceptibility to adenoviral mediated gene transduction, and expression of p53, p16 and pRB. The availability of various urothelial cancer cell lines with differing genotypic and phenotypic features will facilitate further research into bladder cancer.
Authors: Randolph Stone; Anita L Sabichi; Jennifer Gill; I-Ling Lee; Patrick Adegboyega; Michael S Dai; Raja Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford Journal: Cancer Prev Res (Phila) Date: 2010-05-25
Authors: Mai N Tran; Woonyoung Choi; Matthew F Wszolek; Neema Navai; I-Ling C Lee; Giovanni Nitti; Sijin Wen; Elsa R Flores; Arlene Siefker-Radtke; Bogdan Czerniak; Colin Dinney; Michelle Barton; David J McConkey Journal: J Biol Chem Date: 2012-12-13 Impact factor: 5.157
Authors: Hong-Seok Park; Weon Seo Park; Jolanta Bondaruk; Noriyoshi Tanaka; Hiroshi Katayama; Sangkyou Lee; Philippe E Spiess; Jordan R Steinberg; Zhi Wang; Ruth L Katz; Colin Dinney; Keren J Elias; Yair Lotan; Rizwan C Naeem; Keith Baggerly; Subrata Sen; H Barton Grossman; Bogdan Czerniak Journal: J Natl Cancer Inst Date: 2008-09-23 Impact factor: 13.506
Authors: Petros D Grivas; Kathleen C Day; Andreas Karatsinides; Alyssa Paul; Nazia Shakir; Iya Owainati; Monica Liebert; Lakshmi P Kunju; Dafydd Thomas; Maha Hussain; Mark L Day Journal: Mol Med Date: 2013-11-08 Impact factor: 6.354
Authors: Cristina Balbás-Martínez; María Rodríguez-Pinilla; Ariel Casanova; Orlando Domínguez; David G Pisano; Gonzalo Gómez; Josep Lloreta; José A Lorente; Núria Malats; Francisco X Real Journal: PLoS One Date: 2013-05-01 Impact factor: 3.240